Day: April 25, 2024

FORT WORTH, Texas, April 25, 2024 (GLOBE NEWSWIRE) — American Airlines Group Inc. (NASDAQ: AAL) today reported its first-quarter 2024 financial results, including:Record first-quarter revenue of approximately $12.6 billion. First-quarter net loss of $312 million, or ($0.48) per diluted share. Excluding net special items1, first-quarter net loss of $226 million, or ($0.34) per diluted share. Achieved best-ever first-quarter completion factor. Generated operating cash flow of $2.2 billion and free cash flow2 of $1.4 billion in the first quarter. Reduced total debt3 by nearly $950 million in the first quarter. The company is now more than 80% of the way to its 2025 total debt reduction goal.“The American Airlines team continues to build a reliable, efficient and resilient airline,” said American’s CEO Robert Isom. “While we...

ENGLEWOOD CLIFFS. N.J., April 25, 2024 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today reported net income available to common stockholders of $15.7 million for the first quarter of 2024 compared with $17.8 million for the fourth quarter of 2023 and $23.4 million for the first quarter of 2023. Diluted earnings per share were $0.41 for the first quarter of 2024 compared with $0.46 for the fourth quarter of 2023 and $0.59 for the first quarter of 2023. The decrease in net income available to common stockholders and diluted earnings per share from the fourth quarter of 2023 was primarily due to a $1.5 million decrease in net interest income, a $1.3 million increase to the provision for credit losses, and a $0.4 million decrease in noninterest...

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) — Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the first quarter of 2024.First quarter 2024 net revenues1 were $1.1 billion, an increase of 22% over the first quarter of 2023, up 6% organically2 or 7% on a pro forma3 basis, including Adenza in the first quarter of 2023 results for Nasdaq. This included Solutions4 revenue increasing 35%, with organic growth of 11% or 13% on a pro forma basis. Annualized Recurring Revenue (ARR)5 of $2.6 billion increased 29% compared to the first quarter of 2023, up 5% organically or up 7% on a pro forma basis. Financial Technology revenue of $392 million increased 71% over the first quarter of 2023, up 4% organically or 10% on a pro forma basis. Index revenue of $168 million increased 53% and experienced $46 billion of net inflows over...

Continued significant investments to improve reliability and transition to cleaner generation; on track to invest more than $4 billion into our utilities in 2024 Earned the ENERGY STAR Partner of the Year award for sustained excellence in energy efficiency Celebrated 175 years of service at DTE Gas Grew MIGreenPower voluntary renewables program by enrolling Taubman Realty Group and other customers Recognized as a Gallup Exceptional Workplace for 12th consecutive yearDETROIT, April 25, 2024 (GLOBE NEWSWIRE) — DTE Energy (NYSE:DTE) today reported that it invested over $1 billion into improving its electric and natural gas infrastructure in the first quarter of 2024 and is on track to invest over $4 billion this year on a mission to continue improving electric reliability, generating more renewable energy and ensuring continued...

NEWARK, N.Y., April 25, 2024 (GLOBE NEWSWIRE) — Ultralife Corporation (NASDAQ: ULBI) reported operating results for the first quarter ended March 31, 2024 with the following highlights:Sales of $41.9 million representing a 31.4% year-over-year increase, including 54.7% growth in medical market sales Gross profit of $11.5 million, or 27.4% of revenue, compared to $7.4 million, or 23.3% of revenue for the 2023 first quarter Operating income of $4.1 million versus breakeven for the 2023 first quarter GAAP EPS of $0.18 compared to a loss of $0.02 for the 2023 first quarter Adjusted EBITDA of $5.2 million, a four-fold gain compared to $1.2 million last year Backlog of $97.4 million exiting the 2024 first quarter“Ultralife’s strong first quarter results are a testament to the teamwork and success to date of our gross margin improvement...

– Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis- -Appointed Dr. Simon Cooper as Chief Medical Officer- -Anticipate dosing first patient in GARNET Phase 2 study of MORF-057 in patients with moderate-to-severe Crohn’s disease in second quarter- -Ended first quarter with $658.8 million in cash, cash equivalents, and marketable securities; cash runway into second half of 2027- WALTHAM, Mass., April 25, 2024 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today reported corporate highlights and financial results for the first quarter 2024. “Morphic continues to execute our strategy with the EMERALD-2 phase 2b study in ulcerative colitis (UC) recruiting...

First quarter 2024 earnings per share of $1.19Inland marine experienced strong market conditions with a sequential increase in spot market prices and high-teens operating margins despite a sequential increase in delay daysCoastal operating margins improved to high single to low double-digit rangeBreaking out power generation at KDS as its significance continues to grow, constituting 41% of KDS revenues Kirby repurchased 498,505 shares at an average price of $83.82 for $41.8 million in the 2024 first quarterAcquired 13 barges, including three specialty barges, and two high horsepower boats from undisclosed sellerQuarterly earnings expected to strengthen as the year progresses Appoints Christian O’Neil as President and Chief Operating Officer effective April 26, 2024HOUSTON, April 25, 2024 (GLOBE NEWSWIRE) — Kirby...